State of the Science: The Hierarchical Taxonomy of Psychopathology (HiTOP).

clinical utility dimensional nosology transdiagnostic

Journal

Behavior therapy
ISSN: 1878-1888
Titre abrégé: Behav Ther
Pays: England
ID NLM: 1251640

Informations de publication

Date de publication:
Nov 2024
Historique:
received: 26 01 2024
revised: 01 05 2024
accepted: 01 05 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 23 10 2024
Statut: ppublish

Résumé

The Hierarchical Taxonomy of Psychopathology (HiTOP) is a dimensional framework for psychopathology advanced by a consortium of nosologists. In the HiTOP system, psychopathology is grouped hierarchically from super-spectra, spectra, and subfactors at the upper levels to homogeneous symptom components and maladaptive traits and their constituent symptoms, and maladaptive behaviors at the lower levels. HiTOP has the potential to improve clinical outcomes by planning treatment based on symptom severity rather than heterogeneous diagnoses, targeting treatment across different levels of the hierarchy, and assessing distress and impairment separately from the observed symptom profile. Assessments can be performed according to this framework with the recently developed HiTOP-Self-Report (HiTOP-SR). Examples of how to use HiTOP in clinical practice are provided for the internalizing spectrum, including the use of the Unified Protocol and other modularized treatments, measurement-based care, psychopharmacology, and in traditionally underserved populations. Future directions are discussed in this State of the Science review including HiTOP's use in further developing transdiagnostic treatments, extending the model to include other information such as environmental factors, establishing the treatment utility of clinical assessment for the HiTOP-SR, developing new treatments, and disseminating the model.

Identifiants

pubmed: 39443056
pii: S0005-7894(24)00063-7
doi: 10.1016/j.beth.2024.05.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1114-1129

Informations de copyright

Copyright © 2024 Association for Behavioral and Cognitive Therapies. Published by Elsevier Ltd. All rights reserved.

Auteurs

David C Cicero (DC)

University of North Texas. Electronic address: David.cicero@unt.edu.

Camilo J Ruggero (CJ)

University of Texas at Dallas.

Caroline E Balling (CE)

Purdue University.

Angeline R Bottera (AR)

University of Kansas.

Simone Cheli (S)

St. John's University, Rome.

Laurent Elkrief (L)

Université de Montréal.

Kelsie T Forbush (KT)

University of Kansas.

Christopher J Hopwood (CJ)

University of Zurich.

Katherine G Jonas (KG)

Stony Brook University.

Didier Jutras-Aswad (D)

Université de Montréal.

Roman Kotov (R)

Stony Brook University.

Holly F Levin-Aspenson (HF)

University of North Texas.

Stephanie N Mullins-Sweatt (SN)

Oklahoma State University.

Sara Johnson-Munguia (S)

University of Kansas.

William E Narrow (WE)

Johns Hopkins University.

Sonakshi Negi (S)

University of Kansas.

Christopher J Patrick (CJ)

Florida State University.

Craig Rodriguez-Seijas (C)

University of Michigan.

Shreya Sheth (S)

University of North Texas.

Leonard J Simms (LJ)

University at Buffalo.

Marianna L Thomeczek (ML)

University of Kansas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH